Débora Gomes-Medeiros
Research Subjects
Débora Gomes-Medeiros has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Heloísa Scattone
Universidade Estadual de Campinas, Brazil
2 shared publications - Julia Pellizon Mazucco
Faculdade de Medicina de Botucatu, Brasil
2 shared publications - Marcelo Colombini Ranieri
Faculdade de Medicina de Botucatu, Brasil
2 shared publications - Pedro Nicoletti
Universidade de Brasília, Brazil
2 shared publications - Renato Filev
Orientation and Assistance Program for Dependents (Programa de Orientação e Atendimento a Dependentes – PROAD), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
2 shared publications - Edson Thiago Gomes Lima
Department of Chemistry, Federal Rural University of Pernambuco, Recife, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 49 (4) , e153
Therapeutic Uses of Cannabis: An Experience with an Elective Course to Introduce the Content in Undergraduate Medical Education
Introduction: Cannabis sativa L. has a thousand-year history of therapeutic use and scientific evidence of clinical applicability in conditions such as chronic pain, nausea and vomiting associated with chemotherapy, epilepsy and multiple sclerosis, in addition to growing evidence of a potential positive effect in several other morbidities. This great therapeutic potential, justified by the existence of a widely distributed endocannabinoid system with pro-homeostatic functions, is still little present in undergraduate medical school curricula.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 49 (4) , e153
Open AccessTherapeutic Uses of Cannabis: An Experience with an Elective Course to Introduce the Content in Undergraduate Medical Education
Introduction: Cannabis sativa L. has a thousand-year history of therapeutic use and scientific evidence of clinical applicability in conditions such as chronic pain, nausea and vomiting associated with chemotherapy, epilepsy and multiple sclerosis, in addition to growing evidence of a potential positive effect in several other morbidities. This great therapeutic potential, justified by the existence of a widely distributed endocannabinoid system with pro-homeostatic functions, is still little present in undergraduate medical school curricula.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 49 (4) , e153
Usos terapêuticos da Cannabis: experiência de disciplina eletiva para introdução do conteúdo na graduação médica
Introdução: A Cannabis sativa L. possui histórico milenar de uso terapêutico e evidências científicas de aplicabilidade clínica em condições como dor crônica, náuseas e vômitos associados à quimioterapia, epilepsia e esclerose múltipla, além de crescentes evidências de potencial efeito positivo em diversas outras morbidades. Esse grande potencial terapêutico, justificado pela existência de um sistema endocanabinoide amplamente distribuído e com funções pró-homeostáticas, ainda é pouco presente nos currículos da graduação médica.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 49 (4) , e153
Open AccessUsos terapêuticos da Cannabis: experiência de disciplina eletiva para introdução do conteúdo na graduação médica
Introdução: A Cannabis sativa L. possui histórico milenar de uso terapêutico e evidências científicas de aplicabilidade clínica em condições como dor crônica, náuseas e vômitos associados à quimioterapia, epilepsia e esclerose múltipla, além de crescentes evidências de potencial efeito positivo em diversas outras morbidades. Esse grande potencial terapêutico, justificado pela existência de um sistema endocanabinoide amplamente distribuído e com funções pró-homeostáticas, ainda é pouco presente nos currículos da graduação médica.
- 1 June 2022
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 74 (6) , 793-799
Rhamnetin: a review of its pharmacology and toxicity
Objectives: Numerous natural products, including rhamnetin, have been studied in recent years owing to the need for new herbal remedies to treat different illnesses. This study aimed to review the salient properties of rhamnetin and its pharmacological potential and possible toxicological effects. Key findings: A search carried out in the ScienceDirect database using the term ‘rhamnetin’ yielded 573 articles published between 1977 and 2021. However, only those studies that mentioned pharmacological activity of rhamnetin were included in this study. As a result of this selection process, this study included reports that describe rhamnetin as a secondary metabolite with several pharmacological properties. Summary: Rhamnetin (2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one) is a secondary metabolite, belonging to the flavonoid class, present in various plants and fruits; it has different pharmacological properties, including antioxidant, anticancer, anti-inflammatory, antiviral and antibacterial activity. However, conclusive results on the toxicology of rhamnetin have not been reported yet. Therefore, further research is needed to gather detailed information about the effects of rhamnetin.
- 1 June 2022
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 74 (6) , 793-799
Rhamnetin: a review of its pharmacology and toxicity
Objectives: Numerous natural products, including rhamnetin, have been studied in recent years owing to the need for new herbal remedies to treat different illnesses. This study aimed to review the salient properties of rhamnetin and its pharmacological potential and possible toxicological effects. Key findings: A search carried out in the ScienceDirect database using the term ‘rhamnetin’ yielded 573 articles published between 1977 and 2021. However, only those studies that mentioned pharmacological activity of rhamnetin were included in this study. As a result of this selection process, this study included reports that describe rhamnetin as a secondary metabolite with several pharmacological properties. Summary: Rhamnetin (2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one) is a secondary metabolite, belonging to the flavonoid class, present in various plants and fruits; it has different pharmacological properties, including antioxidant, anticancer, anti-inflammatory, antiviral and antibacterial activity. However, conclusive results on the toxicology of rhamnetin have not been reported yet. Therefore, further research is needed to gather detailed information about the effects of rhamnetin.